Narayana Hrudayalaya マネジメント

マネジメント基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Emmanuel Rupert

最高経営責任者

₹75.1m

報酬総額

CEO給与比率	72.0%
CEO在任期間	5.8yrs
CEOの所有権	n/a
経営陣の平均在職期間	5.8yrs
取締役会の平均在任期間	2.5yrs

経営陣の近況

Recent updates

CEO報酬分析

Narayana Hrudayalaya の収益と比較して、Emmanuel Rupert の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Sep 30 2024	n/a	n/a	₹8b
Jun 30 2024	n/a	n/a	₹8b
Mar 31 2024	₹75m	₹54m	₹8b
Dec 31 2023	n/a	n/a	₹8b
Sep 30 2023	n/a	n/a	₹7b
Jun 30 2023	n/a	n/a	₹7b
Mar 31 2023	₹141m	₹47m	₹6b
Dec 31 2022	n/a	n/a	₹5b
Sep 30 2022	n/a	n/a	₹4b
Jun 30 2022	n/a	n/a	₹4b
Mar 31 2022	₹56m	₹33m	₹3b
Dec 31 2021	n/a	n/a	₹3b
Sep 30 2021	n/a	n/a	₹3b
Jun 30 2021	n/a	n/a	₹2b
Mar 31 2021	₹39m	₹28m	-₹143m
Dec 31 2020	n/a	n/a	-₹704m
Sep 30 2020	n/a	n/a	-₹798m
Jun 30 2020	n/a	n/a	-₹310m
Mar 31 2020	₹31m	₹30m	₹1b
Dec 31 2019	n/a	n/a	₹1b
Sep 30 2019	n/a	n/a	₹1b
Jun 30 2019	n/a	n/a	₹936m
Mar 31 2019	₹6m	₹4m	₹592m

報酬と市場: Emmanuelの総報酬 ($USD 890.66K ) は、 Indian市場 ($USD 602.13K ) の同規模の企業の平均を上回っています。

報酬と収益: Emmanuelの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Emmanuel Rupert (57 yo)

5.8yrs

在職期間

₹75,142,254

報酬

Dr. Emmanuel Rupert serves as Managing Director and Group Chief Executive Officer of Narayana Hrudayalaya Limited since February 11, 2019 and also serves as its Director since February 03, 2019. Dr. Rupert...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Devi Shetty	Founder & Executive Chairman	24.3yrs	₹145.57m	16.76% ₹ 44.0b
Emmanuel Rupert	MD, Group CEO & Director	5.8yrs	₹75.14m	データなし
Viren Shetty	Executive Vice-Chairman and Senior VP of Strategy & Planning	16.6yrs	₹33.15m	5.03% ₹ 13.2b
Sandhya Jayaraman	Group Chief Financial Officer	2.9yrs	₹26.01m	データなし
Seshiah Sridhar	Group Company Secretary	7.7yrs	₹10.32m	データなし
R. Venkatesh	Group Chief Operating Officer	1.6yrs	₹5.20m	データなし
Nishant Singh	Vice President of Finance	no data	データなし	データなし
Ashish Bajaj	Chief Marketing Officer	2.3yrs	データなし	データなし
Sirshendu Mookherjee	Group Head of Human Resources	no data	データなし	データなし
Srikanth Raman	Group Head of Internal Audit	no data	₹5.97m	データなし
K. Kumar	Group Head of Information Technology	8.4yrs	データなし	データなし
Milind Inamdar	Senior Vice-President of Supply Chain	10.8yrs	データなし	データなし

5.8yrs

平均在職期間

57yo

平均年齢

経験豊富な経営陣: 539551の経営陣は経験豊富で経験豊富です（平均在職期間は5.8年）。

取締役

名称	ポジション	在職期間	報酬	所有権
Devi Shetty	Founder & Executive Chairman	24.3yrs	₹145.57m	16.76% ₹ 44.0b
Emmanuel Rupert	MD, Group CEO & Director	5.8yrs	₹75.14m	データなし
Viren Shetty	Executive Vice-Chairman and Senior VP of Strategy & Planning	16.6yrs	₹33.15m	5.03% ₹ 13.2b
Nachiket Mor	Independent Director	1.8yrs	₹756.16k	データなし
Kiran Mazumdar-Shaw	Non-Executive Director	16.8yrs	₹2.80m	2.32% ₹ 6.1b
Terri Bresenham	Independent Director	3.3yrs	₹2.82m	データなし
Naveen Tewari	Independent Director	1.7yrs	₹420.55k	データなし
Nivruti Rai	Independent Director	less than a year	₹75.00k	データなし
Anesh Shetty	Non-Executive Non-Independent Director	less than a year	データなし	5.03% ₹ 13.2b
Shankar Arunachalam	Independent Director	1.8yrs	₹706.16k	データなし

2.5yrs

平均在職期間

60yo

平均年齢

経験豊富なボード: 539551の取締役会は経験豊富ではない ( 2.5年の平均在任期間) ため、新しい取締役会が必要であると考えられます。

Narayana Hrudayalaya マネジメント

マネジメント 基準チェック /24

主要情報

経営陣の近況

High number of new directors

High number of new directors

Narayana Hrudayalaya Limited Announces Board Retirements, Effective August 7, 2023

Narayana Hrudayalaya Limited, Annual General Meeting, Aug 04, 2023

Narayana Hrudayalaya Limited Announces Board Appointments

Insufficient new directors

Recent updates

Second quarter 2025 earnings: EPS in line with expectations, revenues disappoint

Narayana Hrudayalaya Limited to Report First Half, 2025 Results on Oct 31, 2024

Now 19% undervalued

High number of new directors

Narayana Hrudayalaya Limited Declares Dividend for the Financial Year Ended March 31, 2024

First quarter 2025 earnings: EPS exceeds analyst expectations

Narayana Hrudayalaya Limited to Report Q1, 2025 Results on Aug 02, 2024

Upcoming dividend of ₹4.00 per share

High number of new directors

New minor risk - Dividend sustainability

Full year 2024 earnings: EPS and revenues miss analyst expectations

Narayana Hrudayalaya Limited Recommends Final Dividend for the Year Ended 31St March, 2024

Narayana Hrudayalaya Limited to Report Q4, 2024 Results on May 24, 2024

Price target increased by 8.1% to ₹1,390

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Narayana Hrudayalaya Limited to Report Q3, 2024 Results on Feb 14, 2024

Investor sentiment improves as stock rises 16%

Price target increased by 7.3% to ₹1,192

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Price target increased by 8.2% to ₹1,070

Narayana Hrudayalaya Limited Approves Dividend for the Financial Year Ended March 31, 2023

Narayana Hrudayalaya Limited Announces Board Retirements, Effective August 7, 2023

Narayana Hrudayalaya Limited to Report Q1, 2024 Results on Aug 02, 2023

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited Proposes Dividend for the Financial Year Ended March 31, 2023

Upcoming dividend of ₹2.50 per share at 0.3% yield

Price target increased by 7.5% to ₹943

Full year 2023 earnings released: EPS: ₹29.85 (vs ₹16.85 in FY 2022)

Narayana Hrudayalaya Limited, Annual General Meeting, Aug 04, 2023

Narayana Hrudayalaya Limited to Report Q4, 2023 Results on May 19, 2023

Price target increased by 7.4% to ₹878

Narayana Hrudayalaya Limited Announces Board Appointments

Narayana Hrudayalaya Limited to Report Q3, 2023 Results on Feb 08, 2023

Narayana Hrudayalaya Limited Files Application for Strike-Off of Name of Wholly Owned Subsidiary, Narayana Health Institutions Private Limited

Insufficient new directors

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited to Report Q2, 2023 Results on Nov 09, 2022

Narayana Hrudayalaya Limited (NSEI:NH) acquired Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited.

Narayana Hrudayalaya Limited (NSEI:NH) signed a Business Transfer Agreement to acquire Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited for INR 2 billion.

Narayana Hrudayalaya Limited (NSEI:NH) signed a Business Transfer Agreement to acquire Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited for INR 2 billion.

Narayana Hrudayalaya Limited Approves the Dividend for the Financial Year Ended 31 March 2022

Upcoming dividend of ₹1.00 per share

Narayana Hrudayalaya Limited Proposes Dividend for the Financial Year Ended 31 March 2022

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited to Report Q1, 2023 Results on Aug 08, 2022

Narayana Health Announces Appointment of Ashish Bajaj as the Chief Marketing Officer

Full year 2022 earnings: EPS misses analyst expectations

Narayana Hrudayalaya Limited Recommends Dividend for the Year Ended March 31, 2022

Insufficient new directors

Insufficient new directors

Narayana Hrudayalaya Limited Announces Appointment of Viren Prasad Shetty as Executive Vice-Chairman

Insufficient new directors

Price target increased to ₹707

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Second quarter 2022 earnings released: EPS ₹4.89 (vs ₹0.17 loss in 2Q 2021)

First quarter 2022 earnings released: EPS ₹3.75 (vs ₹5.90 loss in 1Q 2021)

Additional Non-Executive & Independent Director Nivruti Rai has left the company

Full year 2021 earnings released: ₹0.70 loss per share (vs ₹5.86 profit in FY 2020)

Price target increased to ₹525

Narayana Hrudayalaya Limited to Report Q3, 2021 Results on Feb 05, 2021

Narayana Hrudayalaya Limited Announces Resignation of Manohar Dayaram Chatlani from the Position of Independent Director

Narayana Hrudayalaya Limited Announces Discontinuation of Operation and Sale of Heart Centre in Durgapur, West Bengal

New 90-day high: ₹450

Price target raised to ₹393

New 90-day high: ₹386

New 90-day high: ₹367

Narayana Health in India Joins the Trinetx Network to Drive Innovation and Attract Global Clinical Trials

Second quarter 2021 earnings released: ₹0.17 loss per share

Revenue beats expectations, earnings disappoint

マネジメント基準チェック /24